mdlinx mdlinx
Allergy/Immunology Articles on MDLinx

Differential Diagnosis of Chikungunya, Dengue Viral Infection and Other Acute Febrile Illnesses in Children The Pediatric Infectious Disease Journal, 05/04/2012

Laoprasopwattana K et al. – During a chikungunya (CHIK) outbreak in a dengue viral infection (DVI)–endemic area, overdiagnosis of CHIK was common. Skin rash during fever and white blood cell count > 5000 cells/mm3 or specific antigen testing (if available) can be helpful in differentiating CHIK from DVI.

Methods
  • A prospective cohort study was conducted between April and July 2009 in children aged 1 month to 15 years who lived in a CHIK outbreak area in southern Thailand and who had fever <7 days with arthralgia/arthritis, myalgia or rash.
  • CHIK was confirmed by real-time polymerase chain reaction or the indirect immunofluorescence test.

Results
  • Fifty patients were suspected of having CHIK, of whom 32 were confirmed, 1 had coinfection with dengue viral infection (DVI), 10 had dengue alone and 7 had an acute febrile illness.
  • The specificity and positive predictive value of fever and arthralgia together to diagnose CHIK were 47.1% and 74.2%, and the corresponding values of the standard clinical triad (fever, arthralgia, rash) were 70.6% and 83.3%, respectively.

Read this article on The Pediatric Infectious Disease Journal



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close